vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Legacy Education Inc. (LGCY). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $19.2M, roughly 1.6× Legacy Education Inc.). Legacy Education Inc. runs the higher net margin — 10.6% vs -32.1%, a 42.8% gap on every dollar of revenue. On growth, Legacy Education Inc. posted the faster year-over-year revenue change (40.7% vs -4.5%). Legacy Education Inc. produced more free cash flow last quarter ($512.7K vs $25.0K).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Legacy Education Inc. is a professional educational service provider focused on financial literacy, real estate investment, entrepreneurship, and personal wealth management training programs. It mainly serves individual learners across North America, Europe and select Asia-Pacific markets, offering both in-person workshops and online digital courses to help users build practical financial and business skills.
LFCR vs LGCY — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $19.2M |
| Net Profit | $-10.0M | $2.0M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 13.3% |
| Net Margin | -32.1% | 10.6% |
| Revenue YoY | -4.5% | 40.7% |
| Net Profit YoY | -52.0% | 46.0% |
| EPS (diluted) | $-0.29 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $19.2M | ||
| Q3 25 | $31.1M | $19.4M | ||
| Q2 25 | — | $18.0M | ||
| Q1 25 | $35.2M | $18.6M | ||
| Q4 24 | $32.6M | $13.6M | ||
| Q3 24 | $24.7M | $14.0M | ||
| Q1 24 | $35.7M | — | ||
| Q4 23 | $30.1M | — |
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-10.0M | $2.2M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | $-14.8M | $2.8M | ||
| Q4 24 | $-6.6M | $1.4M | ||
| Q3 24 | $-16.2M | $2.1M | ||
| Q1 24 | $15.6M | — | ||
| Q4 23 | $14.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q1 24 | 33.3% | — | ||
| Q4 23 | 33.0% | — |
| Q4 25 | — | 13.3% | ||
| Q3 25 | -9.9% | 13.9% | ||
| Q2 25 | — | 11.1% | ||
| Q1 25 | -25.7% | 19.7% | ||
| Q4 24 | -6.0% | 12.2% | ||
| Q3 24 | -46.9% | 19.1% | ||
| Q1 24 | -2.5% | — | ||
| Q4 23 | -4.9% | — |
| Q4 25 | — | 10.6% | ||
| Q3 25 | -32.1% | 11.3% | ||
| Q2 25 | — | 6.8% | ||
| Q1 25 | -42.0% | 15.2% | ||
| Q4 24 | -20.2% | 10.3% | ||
| Q3 24 | -65.7% | 14.9% | ||
| Q1 24 | 43.8% | — | ||
| Q4 23 | 47.2% | — |
| Q4 25 | — | $0.15 | ||
| Q3 25 | $-0.29 | $0.16 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | $-0.47 | $0.21 | ||
| Q4 24 | $-0.25 | $0.10 | ||
| Q3 24 | $-0.53 | $0.21 | ||
| Q1 24 | $0.42 | — | ||
| Q4 23 | $0.39 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $21.1M |
| Total DebtLower is stronger | $136.0M | $660.3K |
| Stockholders' EquityBook value | $-10.5M | $46.1M |
| Total Assets | $235.2M | $73.1M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $21.1M | ||
| Q3 25 | $18.9M | $20.6M | ||
| Q2 25 | — | $20.3M | ||
| Q1 25 | $5.4M | $17.3M | ||
| Q4 24 | $9.5M | $16.9M | ||
| Q3 24 | — | $21.5M | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | — | $660.3K | ||
| Q3 25 | $136.0M | $776.9K | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | $124.9M | $1.0M | ||
| Q4 24 | $111.3M | $1.1M | ||
| Q3 24 | $106.3M | $758.2K | ||
| Q1 24 | $97.1M | — | ||
| Q4 23 | $92.9M | — |
| Q4 25 | — | $46.1M | ||
| Q3 25 | $-10.5M | $43.7M | ||
| Q2 25 | — | $41.0M | ||
| Q1 25 | $2.2M | $39.3M | ||
| Q4 24 | $15.4M | $36.4M | ||
| Q3 24 | $-3.9M | $32.6M | ||
| Q1 24 | $17.7M | — | ||
| Q4 23 | $1.4M | — |
| Q4 25 | — | $73.1M | ||
| Q3 25 | $235.2M | $72.1M | ||
| Q2 25 | — | $69.2M | ||
| Q1 25 | $237.7M | $67.1M | ||
| Q4 24 | $255.4M | $62.1M | ||
| Q3 24 | $246.8M | $50.6M | ||
| Q1 24 | $246.2M | — | ||
| Q4 23 | $245.8M | — |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | 56.05× | 0.03× | ||
| Q4 24 | 7.20× | 0.03× | ||
| Q3 24 | — | 0.02× | ||
| Q1 24 | 5.49× | — | ||
| Q4 23 | 65.35× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $1.1M |
| Free Cash FlowOCF − Capex | $25.0K | $512.7K |
| FCF MarginFCF / Revenue | 0.1% | 2.7% |
| Capex IntensityCapex / Revenue | 5.6% | 2.8% |
| Cash ConversionOCF / Net Profit | — | 0.52× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $4.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.1M | ||
| Q3 25 | $1.8M | $1.1M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | $1.2M | $918.7K | ||
| Q4 24 | $-6.1M | $659.0K | ||
| Q3 24 | $-613.0K | $3.2M | ||
| Q1 24 | $-1.4M | — | ||
| Q4 23 | $1.3M | — |
| Q4 25 | — | $512.7K | ||
| Q3 25 | $25.0K | $809.7K | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | $-4.3M | $596.6K | ||
| Q4 24 | $-8.6M | $466.8K | ||
| Q3 24 | $-4.0M | $2.9M | ||
| Q1 24 | $-7.8M | — | ||
| Q4 23 | $-3.0M | — |
| Q4 25 | — | 2.7% | ||
| Q3 25 | 0.1% | 4.2% | ||
| Q2 25 | — | 16.2% | ||
| Q1 25 | -12.1% | 3.2% | ||
| Q4 24 | -26.3% | 3.4% | ||
| Q3 24 | -16.3% | 21.1% | ||
| Q1 24 | -21.8% | — | ||
| Q4 23 | -9.9% | — |
| Q4 25 | — | 2.8% | ||
| Q3 25 | 5.6% | 1.3% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | 15.5% | 1.7% | ||
| Q4 24 | 7.5% | 1.4% | ||
| Q3 24 | 13.9% | 1.7% | ||
| Q1 24 | 17.8% | — | ||
| Q4 23 | 14.1% | — |
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 2.45× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 1.52× | ||
| Q1 24 | -0.09× | — | ||
| Q4 23 | 0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
LGCY
Segment breakdown not available.
